ArticleCureus2016
Correction: Retinopathy and Uveitis Associated with Sofosbuvir Therapy for Chronic Hepatitis C Infection.
Article in Cureus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04159246 (Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir (Sovaldi) in Patients With Hepatitis C Virus Infection
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
- Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus (HCV) patients.International ophthalmology · 2020Article
Corrections and comments
- Erratum for
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
[This corrects the article DOI: 10.7759/cureus.597.].
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.